HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B-cell responses to a peptide epitope: mutations in heavy chain alone lead to maturation of antibody responses.

Abstract
In the present study, the genetic mechanisms responsible for generation of antibodies recognizing the dominant epitope within a synthetic peptide PS1CT3 were examined. PS1CT3 is a peptide model antigen containing residues 28-42 of the large protein of the surface antigen of hepatitis B virus as B epitope (designated PS1), and the known T-helper-cell epitope derived from the circumsporozoite protein of the malaria parasite Plasmodium falciparum (designated CT3). To characterize the repertoire generated, the immunoglobulin heavy chain variable regions from IgM and IgG monoclonal antibodies against PS1CT3 were sequenced. Although all IgG monoclonal antibodies were directed against the immunodominant epitope, the genetic elements used were diverse. Comparison of the sequence of germ line precursor IgM to a mature IgG revealed that during maturation of the primary IgM response only the heavy chain fragment of the antibody molecule underwent somatic mutation.
AuthorsR Tuteja
JournalImmunology (Immunology) Vol. 97 Issue 1 Pg. 1-8 (May 1999) ISSN: 0019-2805 [Print] England
PMID10447708 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Immunodominant Epitopes
  • Immunoglobulin G
  • Immunoglobulin Heavy Chains
  • Immunoglobulin M
  • Peptide Fragments
Topics
  • Animals
  • Antibodies, Monoclonal (biosynthesis)
  • B-Lymphocytes (immunology)
  • Base Sequence
  • Female
  • Immunodominant Epitopes (immunology)
  • Immunoglobulin G (biosynthesis)
  • Immunoglobulin Heavy Chains (genetics)
  • Immunoglobulin M (biosynthesis)
  • Mice
  • Mice, Inbred BALB C
  • Molecular Sequence Data
  • Mutation
  • Peptide Fragments (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: